Endeavor condemns Mawson poison pill defense amid takeover battle
Endeavor Investor Group issued a statement Wednesday condemning Mawson Infrastructure Group’s (NASDAQ: MIGI) adoption of a stockholder rights plan as a move to protect management at the expense of shareholders. The activist investor criticized the board for shielding itself from accountability rather than addressing operational underperformance. “Mawson’s decision to implement the Rights Plan is yet another example of Management acting to entrench itself rather than address the Company’s persistent oper ...